BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2786694)

  • 1. The role of plasmacytoma growth factor in the in vitro responses of murine plasmacytoma cells.
    Nordan RP; Mock BA; Neckers LM; Rudikoff S
    Ann N Y Acad Sci; 1989; 557():200-5. PubMed ID: 2786694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of murine plasmacytoma transferrin receptor expression and G1 traversal by plasmacytoma cell growth factor.
    Neckers LM; Nordan RP
    J Cell Physiol; 1988 Jun; 135(3):495-501. PubMed ID: 3260898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A macrophage-derived factor required by plasmacytomas for survival and proliferation in vitro.
    Nordan RP; Potter M
    Science; 1986 Aug; 233(4763):566-9. PubMed ID: 3726549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor and interleukin 1 can act as essential growth factors in a murine plasmacytoma line.
    Le J; Reis LF; Vilcek J
    Lymphokine Res; 1988; 7(2):99-106. PubMed ID: 3261383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of 5B12.1, a monoclonal antibody specific for IL-6.
    Sawamura M; Everson MP; Shrestha K; Ghanta VK; Miller DM; Hiramoto RN
    Growth Factors; 1990; 3(3):181-90. PubMed ID: 2245041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and NH2-terminal sequence of a plasmacytoma growth factor derived from the murine macrophage cell line P388D1.
    Nordan RP; Pumphrey JG; Rudikoff S
    J Immunol; 1987 Aug; 139(3):813-7. PubMed ID: 3496392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmacytoma growth factor activity of murine granulocyte-macrophage colony-stimulating factor.
    Vink A; Vandenabeele P; Uyttenhove C; Cayphas S; Van Snick J
    J Immunol; 1988 Sep; 141(6):1996-9. PubMed ID: 3049799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-HP1, a T cell-derived hybridoma growth factor that supports the in vitro growth of murine plasmacytomas.
    Van Snick J; Vink A; Cayphas S; Uyttenhove C
    J Exp Med; 1987 Mar; 165(3):641-9. PubMed ID: 3493321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-6 transgenic mouse model for extraosseous plasmacytoma.
    Kovalchuk AL; Kim JS; Park SS; Coleman AE; Ward JM; Morse HC; Kishimoto T; Potter M; Janz S
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1509-14. PubMed ID: 11805288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of lipopolysaccharide-stimulated P388D1 macrophage-like cells on plasmacytoma cells.
    Tseng J; Ferng HC
    Immunol Invest; 1993 Jun; 22(4):283-300. PubMed ID: 8359865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of a role of interleukin 11 in the growth of multiple myeloma.
    Paul SR; Barut BA; Bennett F; Cochran MA; Anderson KC
    Leuk Res; 1992; 16(3):247-52. PubMed ID: 1532843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of two genes on chromosome 4 that determine resistance to plasmacytoma induction in mice.
    Potter M; Mushinski EB; Wax JS; Hartley J; Mock BA
    Cancer Res; 1994 Feb; 54(4):969-75. PubMed ID: 8313388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse plasmacytoma growth in vivo: enhancement by interleukin 6 (IL-6) and inhibition by antibodies directed against IL-6 or its receptor.
    Vink A; Coulie P; Warnier G; Renauld JC; Stevens M; Donckers D; Van Snick J
    J Exp Med; 1990 Sep; 172(3):997-1000. PubMed ID: 2388041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional murine interleukin 6 receptor with the intracisternal A particle gene product at its cytoplasmic domain. Its possible role in plasmacytomagenesis.
    Sugita T; Totsuka T; Saito M; Yamasaki K; Taga T; Hirano T; Kishimoto T
    J Exp Med; 1990 Jun; 171(6):2001-9. PubMed ID: 2112585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of an interleukin HP1-like plasmacytoma growth factor produced by L cells in response to viral infection.
    Cayphas S; Van Damme J; Vink A; Simpson RJ; Billiau A; Van Snick J
    J Immunol; 1987 Nov; 139(9):2965-9. PubMed ID: 3312409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the macrophage-derived hybridoma growth factor in the in vitro and in vivo proliferation of newly formed B cell hybridomas.
    Bazin R; Lemieux R
    J Immunol; 1987 Aug; 139(3):780-7. PubMed ID: 3496390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine interleukin-4 displays potent anti-tumor activity in vivo.
    Tepper RI; Pattengale PK; Leder P
    Cell; 1989 May; 57(3):503-12. PubMed ID: 2785856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell growth and differentiation induced by interleukin-HP1/IL-6, the murine hybridoma/plasmacytoma growth factor.
    Uyttenhove C; Coulie PG; Van Snick J
    J Exp Med; 1988 Apr; 167(4):1417-27. PubMed ID: 2965738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective development of pristane-oil-induced plasmacytomas in interleukin-6-deficient BALB/c mice.
    Lattanzio G; Libert C; Aquilina M; Cappelletti M; Ciliberto G; Musiani P; Poli V
    Am J Pathol; 1997 Sep; 151(3):689-96. PubMed ID: 9284817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of plasmacytomas with silicone gel in genetically susceptible strains of mice.
    Potter M; Morrison S; Wiener F; Zhang XK; Miller FW
    J Natl Cancer Inst; 1994 Jul; 86(14):1058-65. PubMed ID: 8021954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.